Charles Boustany said...

This legislation provides an accelerated route to FDA approval and subsequent limited coverage under Medicare.

This two-pronged approach to jumpstart new innovation in antibiotics, antifungal medications, and diagnostics will not o...

I think it is wrong-headed, and I think it will damage opportunities for seniors to get the best possible care.

We want to thank you guys for bringing these really important proposals forward.